NasdaqGS - Nasdaq Real Time Price USD

Terns Pharmaceuticals, Inc. (TERN)

3.5400
+0.0300
+(0.85%)
At close: June 5 at 4:00:00 PM EDT
3.5200
-0.02
(-0.56%)
Pre-Market: 8:30:24 AM EDT

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
BURROUGHS AMY LOUISE Chief Executive Officer Purchase Nov 29, 2024 19,609
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security Sale Jul 16, 2024 --
KURIAKOSE EMIL T. Officer Sale Apr 1, 2025 53,317
LU HONGBO B Director Purchase Sep 12, 2024 --
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security Sale Jul 16, 2024 --
QUIGLEY JILL M. Director Sale Jan 6, 2025 --
QUIRK ERIN M.D. Officer Stock Award(Grant) Jan 23, 2024 75,000
VIGNOLA MARK J. Chief Financial Officer Sale Jan 6, 2025 74,752
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security Sale Apr 3, 2024 --
YOON SEOKHO BRYAN Chief Operating Officer Purchase May 31, 2024 91,940

Related Tickers